Trial results for a pharmacist intervention aimed at improving mother and child health in Hypertension patients were posted on 2025-08-29, showing that 22 out of 25 enrolled participants returned blood pressure measurements.
Background
Hypertension, particularly when it develops or persists postpartum, poses significant health risks for new mothers. Elevated blood pressure during pregnancy (gestational hypertension or pre-eclampsia) can increase the risk of chronic hypertension and cardiovascular disease later in life. Effective management and monitoring in the postpartum period are crucial for preventing long-term complications for the mother and ensuring the well-being of the child. However, new mothers often face challenges in accessing consistent follow-up care due to time constraints, childcare needs, and other demands. Interventions that facilitate engagement with healthcare providers and support self-monitoring can play a vital role in improving health outcomes for this vulnerable population.
Trial design
This completed study, identified as Phase NA, enrolled 25 participants with Hypertension. The trial investigated a pharmacist intervention designed to improve the health of new mothers and their babies. The main questions aimed to assess the willingness of postpartum women with elevated blood pressure during pregnancy to participate, engage with a pharmacist, and submit blood pressure measurements via text. It also explored whether contact with the pharmacist could improve the health of the mother and/or the child. Participants completed a baseline demographic survey and were provided with a blood pressure cuff and instructions on its use. The study did not list specific primary outcomes in the results data.
Key results
The trial results focused on participant engagement and health metrics within the "Research Pharmacist Monitoring" group:
- The number of participants who talked to the research pharmacist was 20.
- The number of participants who returned blood pressure measurements was 22.
- For 'Percentage of Well-Child Visits Attended', the count was 57 well-child visits.
- For 'Percentage of Vaccinations Received', the count was 251 vaccinations.
- The mean number of blood pressure measurements submitted was 12.9, with a Standard Deviation of 5.3.
- The number of participants achieving blood pressure control was 12.
- The number of participants satisfied with the study was 7.
What this means
The posted results suggest that a pharmacist intervention model can effectively engage postpartum women with hypertension. A high proportion of enrolled participants, 20 out of 25, engaged with the research pharmacist, and 22 participants consistently returned blood pressure measurements. The submission of a mean of 12.9 blood pressure readings per participant indicates active self-monitoring. Furthermore, 12 participants achieved blood pressure control, suggesting a positive impact on maternal health. The reported counts for well-child visits (57) and vaccinations (251) also point towards improved adherence to pediatric care recommendations. While the satisfaction rate of 7 participants might seem low compared to enrollment, the overall engagement and health outcomes indicate the potential utility of such pharmacist-led interventions in supporting postpartum maternal and child health.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT06073054, titled "A Pharmacist Intervention to Improve Mother and Child Health", were posted on 2025-08-29 on clinicaltrials.gov.